A 10.6% increase in sales of its top-selling arthritis drug Humira still couldn't produce positive fourth-quarter earnings for drugmaker AbbVie, the Chicago-based spinoff of Abbott Laboratories.
The White House is proposing $215 million in new funds and new regulations in a sweeping effort involving the NIH, the FDA and the ONC to help fulfill the promise of what President Barack Obama has termed precision medicine.
The antiviral medication Tamiflu shortened the length of time patients experienced flu symptoms, and reduced rates of complications and hospitalizations from the virus, a new study finds. But it did not have an effect on those with flu-like symptoms who did not have the flu.
Harvard Pilgrim Health Care, one of the largest not-for-profit health insurers in New England, said it will save millions of dollars in hepatitis C drug costs through its negotiated pricing discount from pharmaceutical giant Gilead Sciences.
Pharmaceutical industry leaders indicate the federal government's review process for the approval of new drugs and medical devices has improved in recent years, according to new report. But questions remain regarding whether changes to the regulatory process are needed to ensure quicker release of...
The CMS will continue ordering some drug and device manufacturers to collect evidence on how well their technologies work before giving its final approval on reimbursement.
In today's reform environment, the roles of pharmacy and pharmacists are constantly changing, so it's no surprise that the year ahead is likely to present health-system pharmacies with new opportunities, along with elevated responsibilities and risks. Pharmacy leaders will play an even more...
New recommendations on how to improve the safety of compounded, sterile drugs given in hospitals represent a step forward in the fight to prevent more patients from being sickened or killed by mishandled or improperly compounded drugs, experts say.
Long-awaited trials to test two potential vaccines against the Ebola virus will begin in West Africa within the next few weeks, U.S. health officials said Thursday.
Significant gaps remain in ensuring the safety of compounded drugs given in hospitals, reports a study released to Modern Healthcare early Thursday morning by HHS' Office of Inspector General.
President Barack Obama used some of his State of the Union oratory to lay out a grand vision for “precision medicine” and announce an initiative to realize it.
Johnson & Johnson reported a 28% drop in net income and flat sales in the fourth quarter of 2014. The income falloff came about because of the impact of unfavorable currency fluctuations along with charges, including integration costs related to the 2012 acquisition of Synthes, and increased...